{
    "nctId": "NCT02965755",
    "briefTitle": "Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins",
    "officialTitle": "Individualized Molecular Analyses Guide Efforts in Breast Cancer - Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Metastatic Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "Ability of genetically profiling of ptDNA as assessed by identifying the proportion of genetic alterations in tumor tissue",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Male or Female\n* 18 years of age or older\n* Metastatic breast cancer and treatment with prior chemotherapy\n* Any clinical phenotype (Triple negative, Hormone receptor positive, human epidermal growth factor receptor 2 (HER2)-positive)\n* Patient must have received a metastatic tumor biopsy within 3 years prior to the date of the first planned blood sample for the study and have tissue available from this biopsy\n* Able to voluntarily provide informed consent\n\nExclusion Criteria:\n\n* Women who are pregnant or nursing",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}